Discounted Cash Flow
Angiodynamics Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $353.9m | $-43.6m | $42.9m | -12.3% | $-1.21 |
| 2017 | $349.6m (-1.2%) | $5.0m (111.5%) | $5.0m (-88.3%) | 1.4% (111.6%) | $0.14 (111.6%) |
| 2018 | $344.3m (-1.5%) | $16.3m (226.2%) | $38.9m (676.7%) | 4.7% (231.3%) | $0.44 (214.3%) |
| 2019 | $270.6m (-21.4%) | $61.3m (275.5%) | $34.3m (-11.8%) | 22.7% (377.7%) | $1.64 (272.7%) |
| 2020 | $264.2m (-2.4%) | $-166.8m (-371.9%) | $-21.8m (-163.5%) | -63.1% (-378.6%) | $-4.39 (-367.7%) |
| 2021 | $291.0m (10.2%) | $-31.5m (81.1%) | $18.9m (186.8%) | -10.8% (82.8%) | $-0.82 (81.3%) |
| 2022 | $316.2m (8.7%) | $-26.5m (15.9%) | $-11.5m (-160.8%) | -8.4% (22.6%) | $-0.68 (17.1%) |
| 2023 | $338.8m (7.1%) | $-52.4m (-97.5%) | $-3.7m (67.5%) | -15.5% (-84.4%) | $-1.33 (-95.6%) |
| 2024 | $303.9m (-10.3%) | $-184.3m (-251.5%) | $-30.7m (-721.5%) | -60.7% (-291.8%) | $-4.59 (-245.1%) |
| 2025 | $292.5m (-3.8%) | $-34.0m (81.6%) | $-14.6m (52.4%) | -11.6% (80.8%) | $-0.83 (81.9%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.